Skip to content

Equate AQR APO AL/B Duo Control

by Binax, Inc. 510(k)

Active United States

510(k) K903122

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK903122 Date2 Aug 1990ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 5 Oct 2026.

Specification

510(k)

Full name
Equate(Tm) Aqr Apo Al/B Duo Control
510(k) Number
FDA Product Code
DFC
Device Class
Class II
Regulation
21 CFR Part 866.5600
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Equate AQR APO AL/B Duo Control is a Lipoprotein, Low-Density, Antigen, Antiserum, Control as classified under FDA regulation 866.5600. This device serves as a quality control reagent for immunology assays, specifically designed to validate the performance of low-density lipoprotein (LDL) antigen and antiserum tests in diagnostic procedures. It ensures accuracy and consistency in laboratory testing by providing reference standards for comparison.

Supplied as a single-use reagent, the device is intended for use in clinical immunology laboratories. It is regulated under FDA 510(k) clearance (K903122) and falls under Class II medical devices. The product is not described as MRI-safe or reusable, and no additional sterility or storage conditions are specified beyond standard laboratory practices. Authorized for distribution in the United States, it adheres to immunology review panel standards and is categorized under the product code DFC.

Other devices from Binax, Inc.

See all devices from Binax, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Equate AQR APO AL/B Duo Control used for?

    This device is a quality control reagent specifically designed for immunology assays. It serves as a reference standard to validate the performance of low-density lipoprotein (LDL) antigen and antiserum tests in clinical laboratories. By providing a controlled sample, it helps ensure the accuracy and consistency of diagnostic results, which is critical for reliable patient testing.

  • Is the Equate AQR APO AL/B Duo Control single-use or reusable?

    The Equate AQR APO AL/B Duo Control is supplied as a single-use reagent. This design ensures that each test run uses a fresh, uncontaminated sample, reducing the risk of cross-contamination or degradation over time. Single-use controls are standard in clinical laboratories to maintain precision and reliability in diagnostic assays.

  • What regulatory approval does this device hold?

    The Equate AQR APO AL/B Duo Control holds FDA 510(k) clearance under the classification of Lipoprotein, Low-Density, Antigen, Antiserum, Control. It is categorized under product code DFC and falls under Class II medical devices, indicating it has been reviewed and deemed substantially equivalent to a legally marketed device by the FDA.

  • How should the Equate AQR APO AL/B Duo Control be stored?

    While specific storage conditions are not detailed in the provided data, standard laboratory practices should be followed for this single-use reagent. This typically includes storing it in a clean, dry environment, protected from extreme temperatures, direct light, and contamination. Always refer to the manufacturer’s instructions for precise storage guidelines to maintain the integrity of the control.

  • What immunology advisory committee reviewed this device?

    The Equate AQR APO AL/B Duo Control was reviewed by the Immunology (IM) Advisory Committee as part of its FDA 510(k) clearance process. This committee provides expert input on the safety and effectiveness of immunology-related medical devices, ensuring that products like this meet rigorous standards for clinical use in diagnostic testing.